Urology News and Research

Latest Urology News and Research

Bladder, lung cancers are marked by shared differences in genetics that control cell cycle

A University of Colorado Cancer Center study published in the journal PLoS ONE shows that bladder and lung cancers are marked by shared differences in the genetics that control the cell cycle.

30 Jan 2014

Researchers develop classification system to determine prognosis for bladder cancer

Researchers at Lund University have developed a classification system to determine the prognosis for bladder cancer. It is hoped that this will prove useful for future bladder cancer research and drug development.

29 Jan 2014

Serious traumatic spinal cord injuries rising among older people in the U.S.

The number of serious traumatic spinal cord injuries is on the rise in the United States, and the leading cause no longer appears to be motor vehicle crashes, but falls, new Johns Hopkins research suggests.

28 Jan 2014

Number of serious traumatic spinal cord injuries is on the rise in US, shows study

28 Jan 2014

BioTime: OncoCyte initiates clinical development of bladder cancer diagnostic test in U.S, China

BioTime, Inc. and its subsidiary OncoCyte Corporation today announced that OncoCyte has initiated clinical development of its bladder cancer diagnostic test in both the United States and China.

28 Jan 2014

Sling technique boosts post-RARP early continence recovery

Researchers have shown that addition of the bladder neck sling suspension technique to robot-assisted radical prostatectomy can improve the early return of continence after surgery.

27 Jan 2014

Cystoscopy imperative during female incontinence surgery

US researchers say that cystoscopy for lower urinary tract injury should be performed in all women undergoing urinary incontinence surgery, after finding that abnormalities are detected in one in 20 patients.

27 Jan 2014

Actavis signs agreement with Zhejiang Chiral to acquire Actavis Foshan, China

Actavis plc today announced that it has signed and completed an agreement for Zhejiang Chiral Medicine Chemicals Co., Ltd to acquire Actavis' interest in Actavis (Foshan) Pharmaceuticals Co., Ltd., an Actavis subsidiary based in Foshan, China.

25 Jan 2014

Gagnon Cardiovascular Institute adopt new medical device to treat patients with severe aortic stenosis

The Gagnon Cardiovascular Institute at Morristown Medical Center today became the first hospital in the tri-state area to adopt a new minimally invasive medical device to treat patients with severe aortic stenosis who are too ill or frail to have their aortic valves replaced trough traditional open-heart surgery.

25 Jan 2014

Specialists identify opportunities to reduce unnecessary first cesarean deliveries

A recently published article, based on a workshop, Preventing the First Cesarean Delivery: Summary of a Joint Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, and the American College of Obstetricians and Gynecologists Workshop, outlines a collaboration of specialists providing obstetrical care in helping to identify opportunities to reduce unnecessary first cesarean deliveries.

25 Jan 2014

Minimally invasive robotic surgery: A safe alternative to traditional open surgery

A collaboration of surgeons at Henry Ford Hospital and Medanta Hospital in India successfully transplanted kidneys into 50 recipients using an innovative robot-assisted procedure in which the organ is cooled with sterile ice during the operation.

24 Jan 2014

Prostate cancer patients treated with ADT experience mental, emotional well-being during treatment

A new study published in the Journal of Urology- reports that prostate cancer patients treated with androgen deprivation therapy (ADT) experienced changes in mental and emotional well-being during treatment, although there was no meaningful decline in emotional quality of life two years after treatment.

24 Jan 2014

Ipsen decided to launch Somatuline for oncology indications

Ipsen today announced new governance in the United States, following its recently announced decision to launch Somatuline for oncology indications. Marc de Garidel will personally oversee this projected launch.

22 Jan 2014

Study ultimately could lead to development of screening test for diagnosing bladder cancer

Findings from a Loyola University Medical Center study ultimately could lead to tests to screen for and diagnose bladder cancer.

22 Jan 2014

Daytime water restriction effective in nocturia

Researchers from Japan say that some men with nocturia should be advised to restrict their fluid intake during the day and not just at night.

20 Jan 2014

University of Washington develops new device to move kidney stones inside body

Almost one in 10 people will someday experience a kidney stone, which creates what is described as the most intense pain imaginable. This increasingly common condition leads to hundreds of thousands of surgeries in the United States each year.

13 Jan 2014

FDA approves Farxiga tablets to improve glycemic control in adults with type 2 diabetes mellitus

AstraZeneca and Bristol-Myers Squibb Company announced the U.S. Food and Drug Administration approved Farxiga™ [far-SEE-ga] (dapagliflozin), a once-daily oral treatment indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

13 Jan 2014

HoLEP effective for overactive bladder symptoms

Research shows that Holmium laser enucleation of the prostate is effective in improving overactive bladder symptoms and urodynamic parameters in men with benign prostatic hyperplasia.

13 Jan 2014

Nonsurgical treatment improves symptoms in women with pelvic floor dysfunction

One in three women suffer from pelvic floor dysfunction, a range of symptoms which include bladder and bowel problems as well as pelvic pain, according to the American Urogynecologic Society. Now, University of Missouri researchers have demonstrated that a comprehensive, nonsurgical treatment significantly improves symptoms in women with PFD.

10 Jan 2014

Foundation Medicine announces discovery of high incidence of ERBB2 alterations in MPUC patients

Foundation Medicine, Inc. today announced the discovery of a high incidence of ERBB2 (HER2) extracellular domain alterations in patients with micropapillary urothelial carcinoma, a particularly aggressive form of urinary bladder cancer, using FoundationOne. The research was published in the current edition of Clinical Cancer Research.

10 Jan 2014

Urology News and Research

Latest Urology News and Research

Bladder, lung cancers are marked by shared differences in genetics that control cell cycle

Researchers develop classification system to determine prognosis for bladder cancer

Serious traumatic spinal cord injuries rising among older people in the U.S.

Number of serious traumatic spinal cord injuries is on the rise in US, shows study

BioTime: OncoCyte initiates clinical development of bladder cancer diagnostic test in U.S, China

Sling technique boosts post-RARP early continence recovery

Cystoscopy imperative during female incontinence surgery

Actavis signs agreement with Zhejiang Chiral to acquire Actavis Foshan, China

Gagnon Cardiovascular Institute adopt new medical device to treat patients with severe aortic stenosis

Specialists identify opportunities to reduce unnecessary first cesarean deliveries

Minimally invasive robotic surgery: A safe alternative to traditional open surgery

Prostate cancer patients treated with ADT experience mental, emotional well-being during treatment

Ipsen decided to launch Somatuline for oncology indications

Study ultimately could lead to development of screening test for diagnosing bladder cancer

Daytime water restriction effective in nocturia

University of Washington develops new device to move kidney stones inside body

FDA approves Farxiga tablets to improve glycemic control in adults with type 2 diabetes mellitus

HoLEP effective for overactive bladder symptoms

Nonsurgical treatment improves symptoms in women with pelvic floor dysfunction

Foundation Medicine announces discovery of high incidence of ERBB2 alterations in MPUC patients

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Urology News and Research

Latest Urology News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in